23 January 2018
News and Views
Links and Services
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B, reports the latest issue of the Alimentary Pharmacology & Therapeutics.
Delayed hepatitis B e antigen (HBeAg) seroclearance increases the risk of cirrhosis and hepatocel
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors